Cadrenal Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cadrenal Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $0.00.
- Cadrenal Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $16.00K.
- Cadrenal Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $32.00K.
- Cadrenal Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-12-31 was $0.00.
- Cadrenal Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $48.00K.
- Cadrenal Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $250.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $48.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $16.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $32.00K 10-Q · filed 2026-08-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $250.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | |
| 2023-03-31 | $250.00K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |